Early gestation dexamethasone programs enhanced postnatal ovine coronary artery vascular reactivity

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 288, Issue 1 57-1, 2005, Pages

  Roghair, Robert D ^a   Lamb, Fred S ^a   Miller Jr , Francis J ^a   Scholz, Thomas D ^a   Segar, Jeffrey L ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

Author keywords

Angiotensin II; Coronary arteries; Fetal programming; Vascular smooth muscle

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; CORTICOSTEROID; DEXAMETHASONE; PHENYLEPHRINE; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY; FETUS; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; MESENTERIC ARTERY; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECOND MESSENGER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; CAROTID ARTERIES; CORONARY VESSELS; DEXAMETHASONE; FEMALE; FETUS; GESTATIONAL AGE; GLUCOCORTICOIDS; MESENTERIC ARTERIES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SHEEP; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 11144254396     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00165.2004     Document Type: Article

References (32)

1. Anwar MA, Schwab M, Poston L, and Nathanielsz PW. Betamethasone-mediated vascular dysfunction and changes in hematological profile in the ovine fetus. Am J Physiol Heart Circ Physiol 276: H1137-H1143, 1999.
2. Barker DJ, Winter PD, Osmond C, Margetts B, and Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 2: 577-580, 1989.
3. Brawley L, Itoh S, Torrens C, Barker A, Bertram C, Poston L, and Hanson M. Dietary protein restriction in pregnancy induces hypertension and vascular defects in rat male offspring. Pediatr Res 54: 83-90, 2003.
4. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, and Johnson AL. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 165: 196-203, 1989.
5. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, and Stampfer MJ. Prevention of cardiovascular disease: birthweight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 94: 3246-3250, 1996.
6. Docherty CC, Kalmar-Nagy J, Engelen M, Koenen SV, Nijland M, Kuc RE, Davenport AP, and Nathanielsz PW. Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1. Am J Physiol Regul Integr Comp Physiol 281: R261-R268, 2001.
7. Dodic M, Baird R, Hantzis V, Koukoulas I, Moritz K, Peers A, and Wintour EM. Organs/systems potentially involved in one model of programmed hypertension in sheep. Clin Exp Pharmacol Physiol 28: 952-956, 2001.
8. Dodic M, May CN, Wintour EM, and Coghlan JP. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin Sci (Colch) 94: 149-155, 1998.
9. Dodic M, Samuel C, Moritz K, Wintour EM, Morgan J, Grigg L, and Wong J. Impaired cardiac functional reserve and left ventricular hypertrophy in adult sheep after prenatal dexamethasone exposure. Circ Res 89: 623-629, 2001.
10. Hatakeyama H, Inaba S, Takeda R, and Miyamori I. 11Beta-Hydroxysteroid dehydrogenase in human vascular cells. Kidney Int 57: 1352-1357, 2000.
11. Horiuchi M, Akishita M, and Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 33: 613-621, 1999.
12. Lamireau D, Nuyt AM, Hou X, Bernier S, Beauchamp M, Gobeil F, Lahaie I, Varma DR, and Chemtob S. Altered vascular function in fetal programming of hypertension. Stroke 33: 2992-2998, 2002.
13. Langley-Evans SC, Phillips GJ, and Benediktsson R. Protein intake in pregnancy, placental glucocorticoid metabolism, and the programming of hypertension. Placenta 17: 169-172, 1996.
14. Langley-Evans SC, Phillips GJ, Gardner DS, and Jackson AA. Role of glucocorticoids in programming of maternal diet-induced hypertension in the rat. J Nutr Biochem 7: 173-178, 1996.
15. Leon DA, Lithell HO, Vagero D, Koupilova I, Mohsen R, Berglund L, Lithell UB, and McKeigue PM. Reduced fetal growth rate, and increased risk of death from ischaemic heart disease: cohort study of 15,000 Swedish men and women born 1915-1929. Br Med J 317: 241-245, 1998.
16. Lindsay RS, Lindsay RM, Edwards CRW, and Seckl JR. Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 27: 1200-1204, 1996.
17. Molnar J, Howe DC, Nijland MJ, and Nathanielsz PW. Prenatal dexamethasone leads to both endothelial dysfunction and vasodilatory compensation in sheep. J Physiol 547: 61-66, 2003.
18. Murasawa S, Matsubara H, Kanasaki M, Kijima K, Maruyama K, Nio Y, Okubo N, Tsukaguchi H, Mori Y, and Inada M. Characterization of glucocorticoid response element of rat angiotensin II type 1A receptor gene. Biochem Biophys Res Commun 209: 833-840, 1995.
19. Nickenig G and Harrison DG. The AT1-type angiotensin receptor in oxidative stress and atherogenesis. Part I: oxidative stress and atherogenesis. Circulation 105: 393-396, 2002.
20. Nickenig G and Harrison DG. The AT1-type angiotensin receptor in oxidative stress and atherogenesis. Part II: AT1 receptor regulation. Circulation 105: 530-536, 2002.
21. Peers A, Campbell DJ, Wintour EM, and Dodic M. The peripheral renin-angiotensin system is not involved in the hypertension of sheep exposed to prenatal dexamethasone. Clin Exp Pharmacol Physiol 28: 306-311, 2001.
22. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83: 346-356, 1977.
23. Rich-Edwards JW, Stampfer MJ, Manson JE, Rosner B, Hankinson SE, Colditz GA, Willett WC, and Hennekens CH. Birthweight, and risk of cardiovascular disease in a cohort of women followed up since 1976. Br Med J 315: 396-400, 1997.
24. Roghair RD, Lamb FS, Bedell KA, Smith OM, Scholz TD, and Segar JL. Late gestation betamethasone enhances coronary artery responsiveness to angiotensin II in fetal sheep. Am J Physiol Regul Integr Comp Physiol 286: R80-R88, 2004.
25. Schmidt-Ott KM, Kagiyama S, and Phillips MI. The multiple actions of angiotensin II in atherosclerosis. Regul Pept 93: 65-77, 2000.
26. Segar JL, Bedell KA, Page WV, Mazursky JE, Nuyt AM, and Robillard JE. Effect of cortisol on gene expression of the renin-angiotensin system in fetal sheep. Pediatr Res 37: 741-746, 1995.
27. Segar JL, Bedell KA, and Smith OJ. Glucocorticoid modulation of cardiovascular, and autonomic function in preterm lambs: role of ANG II. Am J Physiol Regul Integr Comp Physiol 280: R646-R654, 2001.
28. 1 receptor blockade fails to attenuate pressure-overload cardiac hypertrophy in fetal sheep. Am J Physiol Regul Integr Comp Physiol 273: R1501-R1508, 1997.
29. Smith RD, Chiu AT, Wong PC, Herblin WF, and Timmermans PB. Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu Rev Pharmacol Toxicol 32: 135-165, 1992.
30. Touyz RM and Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000.
31. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, and Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Circulation 81: 482-490, 1990.
32. Zhang C, Hein TW, Wang W, and Kuo L. Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function. Circ Res 92: 322-329, 2003.